• $45.8M
    Market Cap
  • 16.15%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
305,887
+96.56%
155,624
+30.07%
119,650
+124.29%
-492,501
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
305,887
+96.56%
155,624
+30.07%
119,650
+124.29%
-492,501
-96.09%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-11.5M
-28.60%
-16.1M
+35.57%
-11.9M
+38.26%
-8.6M
+13.64%
Depreciation and Amortization Expense
17,280
-0.01%
17,282
+18.25%
14,615
+44.98%
10,081
+49.11%
Total Operating Expenses
18.0M
-19.08%
22.2M
+24.27%
17.9M
+23.87%
14.4M
+14.62%
Operating Profit
-18.0M
-19.08%
-22.2M
+24.27%
-17.9M
+23.87%
-14.4M
+16.74%
Interest Income
437,931
-41.01%
742,355
-3.01%
765,388
+274.54%
204,355
+200.84%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
437,931
-41.01%
742,355
-3.01%
765,388
+274.54%
204,355
+200.84%
Total Nonoperating Income and Expense
421,125
-39.22%
692,869
-39.78%
1.2M
+3,747.29%
-31,548
-119.65%
Income before Taxes
-18.0M
-19.08%
-22.2M
+24.27%
-17.9M
+23.87%
-14.4M
+16.74%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-17.2M
-15.94%
-20.5M
+28.56%
-16.0M
+11.93%
-14.3M
+15.34%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-16.0M
+11.93%
-14.3M
+15.34%
Basic EPS and Net Income
-1.57
-18.65%
-1.93
+31.29%
-1.47
+12.21%
-1.31
+15.93%
Diluted EPS and Net Income
-1.57
-18.65%
-1.93
+31.29%
-1.47
+12.21%
-1.31
+15.93%
Basic Weighted Average Shares
10.9M
+1.26%
10.8M
-0.74%
10.8M
-0.08%
10.9M
-0.50%
Diluted Weighted Average Shares
10.9M
+1.26%
10.8M
-0.74%
10.8M
-0.08%
10.9M
-0.50%
Balance Sheet
Cash and Cash Equivalents
4.4M
-41.12%
7.5M
-65.76%
21.9M
-41.03%
37.2M
-27.80%
Short-Term Investments
5.7M
-65.48%
16.5M
-14.78%
19.4M
+7.62%
18.0M
-6.29%
Cash and Cash Equivalents and Short-Term Investments
10.1M
-57.86%
24.0M
-41.86%
41.3M
-25.17%
55.2M
-21.96%
Total Current Assets
10.8M
-57.21%
25.2M
-41.75%
43.3M
-26.19%
58.7M
-19.24%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
31,875
-32.81%
47,440
-8.99%
52,127
+8.58%
48,008
+58.73%
Total Long-Term Assets
36,738
0.00%
36,738
+42.02%
25,869
+44.61%
17,889
0.00%
Total Assets
11.0M
-56.84%
25.6M
-41.41%
43.6M
-25.82%
58.8M
-20.44%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.5M
+3.93%
4.3M
+61.72%
2.7M
-4.29%
2.8M
+20.30%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
78,539
+48.63%
52,843
-14.07%
61,496
+16.27%
52,890
0.00%
Total Liabilities
4.5M
+2.68%
4.4M
+60.02%
2.7M
-2.09%
2.8M
+17.62%
Retained Earnings
-93.1M
+22.52%
-76.0M
+37.62%
-55.2M
+40.63%
-39.3M
+56.99%
Total Stockholders Equity
N/A
N/A
N/A
N/A
40.9M
-27.00%
56.0M
-21.70%
Total Shares Outstanding
11.3M
+4.36%
10.8M
+0.59%
10.7M
-1.25%
10.9M
-2.09%
Cash Flow
Cash from Operating Activities
-15.7M
-11.99%
-17.8M
+24.16%
-14.3M
+12.37%
-12.8M
+20.54%
Capital Expenditures
1,715
-86.38%
12,595
-32.77%
18,734
-32.72%
27,844
N/A
Cash from Investing Activities
11.1M
+228.16%
3.4M
+462.22%
-930,210
-618.89%
179,268
+100.92%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.5M
+2,145.90%
66,710
+113.34%
-499,997
-77.09%
-2.2M
-103.44%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-5,877.50%
-58.83%
-14,275.71%
-4.46%
-14,941.55%
-609.86%
2,930.50%
N/A
Return on Assets
-94.23%
+58.94%
-59.29%
+90.34%
-31.15%
+45.03%
-21.48%
-18.08%
Return on Equity
N/A
N/A
N/A
N/A
-32.93%
+47.34%
-22.35%
-17.50%
Revenue Growth
96.56%
+221.14%
30.07%
-75.81%
124.29%
N/A
N/A
N/A
Current Ratio
2.40
-58.83%
5.83
-63.98%
16.18
-22.88%
20.99
-32.87%
Cash Ratio
0.98
-43.35%
1.73
-78.83%
8.19
-38.39%
13.29
-39.98%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow